Two Sigma Advisers’s Kezar Life Sciences KZR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Sell |
54,641
-9,868
| -15% | -$45.2K | ﹤0.01% | 2033 |
|
|
2025
Q1 | $315K | Sell |
64,509
-35,632
| -36% | -$174K | ﹤0.01% | 1970 |
|
|
2024
Q4 | $673K | Sell |
100,141
-40,149
| -29% | -$270K | ﹤0.01% | 1650 |
|
|
2024
Q3 | $1.08M | Buy |
140,290
+16,530
| +13% | +$128K | ﹤0.01% | 1375 |
|
|
2024
Q2 | $743K | Buy |
123,760
+580
| +0.5% | +$3.48K | ﹤0.01% | 1707 |
|
|
2024
Q1 | $1.11M | Sell |
123,180
-9,050
| -7% | -$81.6K | ﹤0.01% | 1540 |
|
|
2023
Q4 | $1.25M | Buy |
132,230
+65,240
| +97% | +$618K | ﹤0.01% | 1532 |
|
|
2023
Q3 | $797K | Sell |
66,990
-20,740
| -24% | -$247K | ﹤0.01% | 1614 |
|
|
2023
Q2 | $2.15M | Buy |
87,730
+35,170
| +67% | +$862K | 0.01% | 1160 |
|
|
2023
Q1 | $1.65M | Buy |
52,560
+14,590
| +38% | +$457K | ﹤0.01% | 1374 |
|
|
2022
Q4 | $2.67M | Sell |
37,970
-9,300
| -20% | -$655K | 0.01% | 1082 |
|
|
2022
Q3 | $4.07M | Sell |
47,270
-18,210
| -28% | -$1.57M | 0.01% | 837 |
|
|
2022
Q2 | $5.42M | Buy |
65,480
+15,530
| +31% | +$1.28M | 0.02% | 735 |
|
|
2022
Q1 | $8.3M | Sell |
49,950
-1,230
| -2% | -$204K | 0.02% | 593 |
|
|
2021
Q4 | $8.56M | Buy |
51,180
+23,010
| +82% | +$3.85M | 0.02% | 555 |
|
|
2021
Q3 | $2.43M | Buy |
28,170
+6,910
| +33% | +$597K | 0.01% | 1144 |
|
|
2021
Q2 | $1.15M | Sell |
21,260
-3,870
| -15% | -$210K | ﹤0.01% | 1571 |
|
|
2021
Q1 | $1.5M | Sell |
25,130
-3,530
| -12% | -$210K | ﹤0.01% | 1418 |
|
|
2020
Q4 | $1.5M | Sell |
28,660
-1,460
| -5% | -$76.2K | ﹤0.01% | 1398 |
|
|
2020
Q3 | $1.46M | Buy |
30,120
+20,090
| +200% | +$972K | ﹤0.01% | 1327 |
|
|
2020
Q2 | $520K | Buy |
10,030
+3,620
| +56% | +$188K | ﹤0.01% | 1869 |
|
|
2020
Q1 | $279K | Buy |
6,410
+1,370
| +27% | +$59.6K | ﹤0.01% | 2042 |
|
|
2019
Q4 | $202K | Sell |
5,040
-1,300
| -21% | -$52.1K | ﹤0.01% | 2187 |
|
|
2019
Q3 | $208K | Buy |
+6,340
| New | +$208K | ﹤0.01% | 2031 |
|